A detailed history of Simplex Trading, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 621 shares of ANIP stock, worth $35,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
621
Holding current value
$35,136
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$54.33 - $65.72 $33,738 - $40,812
621 New
621 $37,000
Q4 2022

Feb 02, 2023

BUY
$31.9 - $41.95 $35,217 - $46,312
1,104 Added 2760.0%
1,144 $46,000
Q3 2022

Nov 04, 2022

BUY
$29.83 - $38.01 $1,193 - $1,520
40 New
40 $1,000
Q2 2021

Aug 12, 2021

BUY
$31.86 - $38.6 $3,823 - $4,632
120 Added 222.22%
174 $6,000
Q1 2021

Apr 26, 2021

SELL
$28.4 - $36.14 $19,539 - $24,864
-688 Reduced 92.72%
54 $1,000
Q4 2020

Feb 02, 2021

BUY
$23.69 - $31.47 $17,577 - $23,350
742 New
742 $21,000
Q3 2020

Oct 14, 2020

SELL
$26.38 - $33.1 $17,226 - $21,614
-653 Closed
0 $0
Q2 2020

Jul 13, 2020

SELL
$29.93 - $50.1 $27,954 - $46,793
-934 Reduced 58.85%
653 $21,000
Q1 2020

Apr 29, 2020

SELL
$30.35 - $67.14 $9,620 - $21,283
-317 Reduced 16.65%
1,587 $64,000
Q4 2019

Feb 05, 2020

SELL
$55.65 - $79.83 $568,242 - $815,144
-10,211 Reduced 84.28%
1,904 $117,000
Q3 2019

Oct 15, 2019

BUY
$64.7 - $85.39 $663,239 - $875,332
10,251 Added 549.95%
12,115 $882,000
Q2 2019

Jul 26, 2019

SELL
$67.77 - $82.2 $155,125 - $188,155
-2,289 Reduced 55.12%
1,864 $153,000
Q1 2019

Apr 18, 2019

SELL
$45.83 - $70.54 $62,832 - $96,710
-1,371 Reduced 24.82%
4,153 $0
Q4 2018

Jan 16, 2019

BUY
$41.17 - $56.44 $227,423 - $311,774
5,524 New
5,524 $248,000
Q1 2018

Apr 26, 2018

SELL
$56.98 - $72.41 $26,495 - $33,670
-465 Closed
0 $0
Q4 2017

Jan 10, 2018

BUY
$53.3 - $74.56 $24,784 - $34,670
465
465 $29,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.